Related references
Note: Only part of the references are listed.Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
Frederic A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Updates on the Treatment of Lupus Nephritis
Andrew S. Bomback et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
David Isenberg et al.
RHEUMATOLOGY (2010)
A Retrospective Seven-Year Analysis of the Use of B Cell Depletion Therapy in Systemic Lupus Erythematosus at University College London Hospital: The First Fifty Patients
Tim Y-T. Lu et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials
Bin Zhu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial
C. Grootscholten et al.
KIDNEY INTERNATIONAL (2006)
Outcomes in African Americans and Hispanics with lupus nephritis
G. Contreras et al.
KIDNEY INTERNATIONAL (2006)
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
R. Andrew Moore et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
EM Ginzler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
DA Isenberg et al.
RHEUMATOLOGY (2005)
Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis
TM Chan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Sequential therapies for proliferative lupus nephritis
G Contreras et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The classification of glomerulonephritis in systemic lupus erythematosus revisited
JJ Weening et al.
KIDNEY INTERNATIONAL (2004)
Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus -: An open-label study
M Aringer et al.
ARTHRITIS AND RHEUMATISM (2004)
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial -: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial
FA Houssiau et al.
ARTHRITIS AND RHEUMATISM (2004)
Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome
M El Hachmi et al.
LUPUS (2003)
Immunosuppressive therapy in lupus nephritis -: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
FA Houssiau et al.
ARTHRITIS AND RHEUMATISM (2002)
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
TM Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Mycophenolate mofetil and its mechanisms of action
AC Allison et al.
IMMUNOPHARMACOLOGY (2000)
Share Paper
